01
Platforms that don't break.
Azure-first infrastructure with AKS, Terraform, GitHub Actions, and observability that actually wakes the right person at the right time.
Vol. I · No. 01 A working portfolio Lubbock · Amarillo · Phoenix
§ 01 Cover
Camron
Lacy Shelton.
Platform engineer, technical communicator, and Red Raider. A Navy-trained electronics technician turned Azure architect, with twenty-plus years split between writing systems and writing about them. Founder of NxGen AI Labs and an unrepentant academic — currently finishing a Master's in Computer Science at Texas Tech.
§ 02The pitch
Three lines I keep sharp. They compound.
02
Writing that earns its space.
Master's candidate in Technical Communication at Texas Tech. Research focus on rhetoric in health and medicine — language is infrastructure too.
03
AI products with a conscience.
Founder of NxGen AI Labs — Veltoria for chat, NxResolve for autonomous ops, NxCode for multi-agent engineering. Human-in-the-loop on what matters.
§ 03Projects
Things I'm building.
- 01 Founder · Platform ↗
NxGen AI Labs
Parent company building AI-native products. Monorepo platform across Veltoria, NxResolve, and NxCode — TypeScript, Next.js, Azure.
- 02 AI Product ↗
Veltoria
Branded AI chat platform — full-fidelity chat experience built on LibreChat (MIT) with custom auth, tenancy, and enterprise tooling.
- 03 AI Product ↗
NxResolve
Autonomous operations remediation. Per-tenant isolated MCP servers, customer-set cost guardrails, and human-in-the-loop gates on every risky action.
- 04 AI Product ↗
NxCode
Multi-agent coding platform. Architect, Implementer, Reviewer, Security Auditor, and QA agents coordinate until consensus on production-ready code.
§ 04Writing
From the desk.
Research, case studies, and longer pieces — every one comes with an inline reader and a download.
-
Mobley v. Workday — Case Study
Case study examining Mobley v. Workday and the emerging legal landscape around algorithmic hiring tools, AI bias, and employer liability under federal anti-discrimination law.
Read → -
Unpacking the Rhetoric: Marketing Strategies of Ozempic, Wegovy, and Mounjaro
Rhetorical analysis of GLP-1 receptor agonist marketing — how Ozempic, Wegovy, and Mounjaro frame diabetes care and weight loss across professional and consumer audiences.
Read → -
Annotated Bibliography — GLP-1 & Weight Loss Rhetoric
Annotated bibliography supporting research into the rhetoric surrounding diabetic medications repurposed for weight loss.
Read →
§ 05An invitation
Got something worth building?
Hard infrastructure problems, AI builds with stakes, technical writing that has to be precise. Send a note — I read everything, I reply to what's interesting.